|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/155 | (2006.01) |
| C12N 15/861 | (2006.01) | ||
| C12N 15/863 | (2006.01) | ||
| C07K 16/44 | (2006.01) |
| (11) | Number of the document | 2869841 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13734111.1 |
| Date of filing the European patent application | 2013-07-05 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (86) | Number | PCT/EP2013/064286 |
| Date | 2013-07-05 |
| (87) | Number | WO 2014/006191 |
| Date | 2014-01-09 |
| (30) | Number | Date | Country code |
| PCT/EP2012/063196 | 2012-07-05 | WO |
| (72) |
NICOSIA, Alfredo , IT
CORTESE, Ricardo , BE
VITELLI, Alessandra , IT
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut 89, 1330 Rixensart,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji sužadinantys-sustiprinantys režimai, apimantys polinukleotidų koduojamus imunogeninius polipeptidus |
| NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES |
| Payment date | Validity (years) | Amount | |
| 2024-06-19 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-08-05 |